This inventor holds 1 USPTO granted patent. Top assignee: North American Vaccine, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Catherine Dong - Innovator in Vaccine Development
Introduction
Catherine Dong is a prominent inventor based in Arlington, VA (US). She has made significant contributions to the field of vaccine development, particularly in the area of Group B Streptococcus.
Latest Patents
Catherine Dong holds a patent for "Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof." This patent discloses a process for depolymerizing Group B Types II and III Streptococcus, resulting in polysaccharide fragments suitable for conjugation to proteins. The patent also covers conjugate molecules, vaccines, and their use to immunize mammals, including humans.
Career Highlights
Catherine is associated with North American Vaccine, Inc., where she has been instrumental in advancing vaccine technologies. Her work has the potential to impact public health significantly.
Collaborations
Catherine has collaborated with notable colleagues, including Francis Michon and Joseph Y Tai, to further her research and development efforts in vaccine innovation.
Conclusion
Catherine Dong is a key figure in the field of vaccine development, with her innovative work paving the way for advancements in immunization against Group B Streptococcus. Her contributions are vital to the ongoing efforts in public health and vaccine research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile